PressRelease,AACR25,crcsm,CRISPR,coloncancer,CISH

Mashup Score: 17

Data from First-in-Human Trial targeting CISH, a Novel Immune Checkpoint, in Patients with Metastatic Colorectal Cancer Presented at 2025 American Association for Cancer Research (AACR) Annual Meeting - 6 day(s) ago

/PRNewswire/ — Intima Bioscience, a clinical stage oncology company focused on curative intent in solid tumor cancers, presented data from a first-in-human…

Source: www.prnewswire.com

Categories: General Medicine News

Tweet Tweets with this article
- cancerassassin1
  
  #PressRelease via @PRNewswire on Data from First-in-Human Trial targeting CISH, a Novel Immune Checkpoint, in Patients with Metastatic Colorectal Colorectal Cancer - trial results presented April 29 at @AACR #AACR25 https://t.co/z03eIWb5ov #crcsm #CRISPR #coloncancer #CISH